Author: The Lanier Law Firm

Mark Lanier Leading Efforts to Consolidate Business-Related COVID-19 Coverage Claims In Federal MDL

In a 90-minute video hearing before the Judicial Panel on Multidistrict Litigation, the firm’s Mark Lanier advocated for a national consolidation of the growing number of COVID-19-related business interruption claims against insurers.

Mr. Lanier told the seven-member panel that centralizing those cases in federal court would create a consistency among any differing interpretations of policy language. Continue reading “Mark Lanier Leading Efforts to Consolidate Business-Related COVID-19 Coverage Claims In Federal MDL”

Missouri Appellate Court Denies Reconsideration of $2.11 Billion Talc-Ovarian Cancer Ruling

The Missouri Court of Appeals has denied an effort by Johnson & Johnson’s legal counsel to seek a rehearing of the court’s recent opinion that upheld $2.11 billion in punitive and compensatory damages against the company and its affiliate.  The court also denied J&J’s efforts to transfer the ruling to the Missouri Supreme Court. Continue reading “Missouri Appellate Court Denies Reconsideration of $2.11 Billion Talc-Ovarian Cancer Ruling”

Whistleblower Lawsuit: Tamiflu Maker Won $1.4B Contract after Deceiving the CDC about Drug’s Pandemic Effectiveness

New legal filing reveals extent of deception by Tamiflu maker Hoffmann-La Roche

BALTIMORE – Drug company Hoffmann-La Roche (OTCMKTS – RHHBY) falsified scientific conclusions and mounted a high-powered marketing and lobbying campaign to deceive the government about the effectiveness of Tamiflu (oseltamivir) for fighting a flu pandemic, according to new filings in a federal False Claims Act lawsuit. The case seeks to recover more than $1.4 billion of taxpayer dollars that the federal government wrongly spent to add Tamiflu to the Strategic National Stockpile. Continue reading “Whistleblower Lawsuit: Tamiflu Maker Won $1.4B Contract after Deceiving the CDC about Drug’s Pandemic Effectiveness”

Missouri Appellate Court Finds “Reprehensible” Conduct By J&J in $2.1 Billion Verdict

 2018 jury award reduced due to jurisdictional issues

ST. LOUIS — A Missouri appellate court has unanimously upheld a St. Louis jury’s determination that Johnson & Johnson engaged in “reprehensible conduct” by manufacturing and selling asbestos-containing talcum powder products over the course of many decades. Continue reading “Missouri Appellate Court Finds “Reprehensible” Conduct By J&J in $2.1 Billion Verdict”